Spots Global Cancer Trial Database for cxcr4
Every month we try and update this database with for cxcr4 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Safety Study of a Chemokine Receptor (CXCR4) Antagonist in Multiple Myeloma Patients | NCT01010880 | Multiple Myelom... | BKT140 | 16 Years - 65 Years | Biokine Therapeutics Ltd | |
CXCR4 Targeted PET Imaging in APA Preoperative Localization Diagnosis | NCT05839483 | Aldosterone-Pro... | CXCR4 | 18 Years - 70 Years | Zhongnan Hospital | |
The Role of MMPs in the CXCL12-Induced Invasion of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma | NCT00302562 | Laryngeal Cance... Hypopharyngeal ... | 30 Years - 75 Years | National Taiwan University Hospital | ||
Gallium 68 Pentixafor in Patients With Neuroendocrine Tumors | NCT03335670 | Neuroendocrine ... | [68Ga]Pentixafo... | 18 Years - | University of Iowa | |
The Role of SDF-1/CXCR4 in Metastasis of Oral Squamous Cell Carcinoma | NCT00173849 | Oral Cancer | 30 Years - 75 Years | National Taiwan University Hospital | ||
CXCR4 Targeted PET Imaging in APA Preoperative Localization Diagnosis | NCT05839483 | Aldosterone-Pro... | CXCR4 | 18 Years - 70 Years | Zhongnan Hospital | |
Safety Study of a Chemokine Receptor (CXCR4) Antagonist in Multiple Myeloma Patients | NCT01010880 | Multiple Myelom... | BKT140 | 16 Years - 65 Years | Biokine Therapeutics Ltd | |
The Role of MMPs in the CXCL12-Induced Invasion of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma | NCT00302562 | Laryngeal Cance... Hypopharyngeal ... | 30 Years - 75 Years | National Taiwan University Hospital | ||
The Role of Stromal Cell-Derived Factor-1 (SDF-1)/CXC Chemokine Receptor 4 (CXCR4) in Metastasis of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma | NCT00174096 | Laryngeal Cance... Hypopharyngeal ... Metastasis | 30 Years - 75 Years | National Taiwan University Hospital | ||
Chemosensitization With Plerixafor Plus G-CSF in Acute Myeloid Leukemia | NCT00906945 | Leukemia, Myelo... | G-CSF Plerixafor Mitoxantrone Etoposide Cytarabine | 18 Years - 70 Years | Washington University School of Medicine | |
The Role of Stromal Cell-Derived Factor-1 (SDF-1)/CXC Chemokine Receptor 4 (CXCR4) in Metastasis of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma | NCT00174096 | Laryngeal Cance... Hypopharyngeal ... Metastasis | 30 Years - 75 Years | National Taiwan University Hospital | ||
Gallium 68 Pentixafor in Patients With Neuroendocrine Tumors | NCT03335670 | Neuroendocrine ... | [68Ga]Pentixafo... | 18 Years - | University of Iowa | |
The Role of SDF-1/CXCR4 in Metastasis of Oral Squamous Cell Carcinoma | NCT00173849 | Oral Cancer | 30 Years - 75 Years | National Taiwan University Hospital | ||
CXCR4 PET/MRI Targeted Imaging for Grading Diagnosis, Molecular Typing, and Prognostic Evaluation of Brain Glioma | NCT06234319 | Glioma | CXCR4 | 18 Years - | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | |
AMD3100 Plus Mitoxantrone, Etoposide and Cytarabine in Acute Myeloid Leukemia | NCT00512252 | Leukemia, Myelo... | AMD3100 Mitoxantrone Etoposide Cytarabine | 18 Years - 70 Years | Washington University School of Medicine |